Speaker illustration

Professor Zuzana Motovska

Charles University of Prague, Prague (Czechia)

Member of:

European Society of Cardiology

Impact of COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction.

Event: ESC Congress 2022

Topic: Cardiogenic Shock

Session: Acute cardiac care and COVID

Thumbnail

Case 2 - My P2Y12 inhibitor choice for a patient presenting with STEMI.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Acute Coronary Syndromes

Session: Which P2Y12 Inhibitor for Patients with Acute Coronary Syndromes?

Thumbnail

Intense antithrombotic therapy is necessary for long-term treatment in patients with symptomatic peripheral artery disease after acute myocardial infarction and primary PCI

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pharmacotherapy

Session: Acute Coronary Syndromes ePosters

Thumbnail

Dual antithrombotic therapy is similarly effective to triple therapy in preventing thrombotic events in patients with atrial fibrillation and acute coronary syndrome

Event: ESC CONGRESS 2019

Topic: Oral Anticoagulation

Session: Atrial fibrillation and oral anticoagulation 5

Thumbnail

MiR-126-3P and MiR-223-3p in Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty, The Prague-18 Genetic Sub-study

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: Cardiac troponins and other biomarkers in acute coronary syndromes

Thumbnail

Predictors and case fatality rate of perioperative major cardiovascular events in cardiac patients undergoing non-cardiac surgery.

Event: ESC CONGRESS 2017

Topic: Risk scores

Session: Risk estimation in high risk individuals

Thumbnail

This platform is supported by

logo Novo Nordisk